Source: Proxy Biomedical Blog

Proxy Biomedical Blog Proxy Biomedical to Attend LINC 2017 Conference

Proxy Biomedical will be attending LINC 2017, The Leipzig Interventional Course in January. The company specialises in biomaterial coverings for vascular implants, facilitating novel implant designs and improvements of next generation devices in peripheral, endovascular, structural heart and neurovascular applications. Solutions include PTFE covering of balloon/ self-expanding stents and structural heart implants; coating solutions for vascular implants, such occlusion and retrieval devices, as well [...]The post Proxy Biomedical to Attend LINC 2017 Conference appeared first on Proxy BioMedical.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Peter Mulrooney's photo - CEO of Proxy Biomedical

CEO

Peter Mulrooney

CEO Approval Rating

70/100

Read more